| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 344,772 | 391,134 | ||
| Accounts receivable, net | 30,768 | 30,412 | ||
| Inventory | 3,488 | 3,039 | ||
| Prepaid expenses and other current assets | 7,952 | 8,790 | ||
| Total current assets | 386,980 | 433,375 | ||
| Property and equipment, net | 16,954 | 10,461 | ||
| Restricted cash | 1,614 | 1,614 | ||
| Operating lease assets | 5,334 | 5,883 | ||
| Total assets | 410,882 | 451,333 | ||
| Accounts payable | 6,260 | 5,889 | ||
| Accrued expenses and other current liabilities | 40,272 | 34,417 | ||
| Operating lease liabilities | 2,762 | 2,625 | ||
| Total current liabilities | 49,294 | 42,931 | ||
| Operating lease liabilities, net of current portion | 3,629 | 4,408 | ||
| Derivative liability | 14,962 | 14,024 | ||
| Deferred revenue, net of current portion | 14,000 | 14,000 | ||
| Notes payable, net | 70,617 | 69,906 | ||
| Other non-current liabilities | 151 | 148 | ||
| Total liabilities | 152,653 | 145,417 | ||
| Common stock, 0.0001 par value 400,000,000 and 400,000,000 shares authorized and 174,949,558 and 157,749,490 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 18 | 17 | ||
| Additional paid-in capital | 1,350,580 | 1,328,850 | ||
| Accumulated deficit | -1,092,369 | -1,022,951 | ||
| Total stockholders' equity | 258,229 | 305,916 | ||
| Total liabilities and stockholders' equity | 410,882 | 451,333 | ||
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)